Page last updated: 2024-09-04

lexapro and nisoldipine

lexapro has been researched along with nisoldipine in 1 studies

Compound Research Comparison

Studies
(lexapro)
Trials
(lexapro)
Recent Studies (post-2010)
(lexapro)
Studies
(nisoldipine)
Trials
(nisoldipine)
Recent Studies (post-2010) (nisoldipine)
1701280316851

Protein Interaction Comparison

ProteinTaxonomylexapro (IC50)nisoldipine (IC50)
Cytochrome P450 1A2Homo sapiens (human)1
Adenosine receptor A3Homo sapiens (human)7.12
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.12
Voltage-dependent L-type calcium channel subunit alpha-1CRattus norvegicus (Norway rat)0.003
Adenosine receptor A2aHomo sapiens (human)4.058
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.12
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)0.003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for lexapro and nisoldipine

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013